Pharmafile Logo
Pharmafocus logo
Advanced Search

WHO

Showing 15 posts of 102 posts found.

Freeman image

George Freeman: UK pharma is vital for our landscape

December 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, WHO, freeman, medicine, stratified

The ABPI says the UK has an opportunity to benefit from stratified medicine, and the body’s 2014 conference held in …

Feature
GSK image

GSK Ebola vaccine ‘promising’ in early trials

November 27, 2014
Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines

The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …

News

UK lags behind in healthcare outcomes index

November 26, 2014
Research and Development, Sales and Marketing Japan, NHS, UK, WHO, economist, health outcomes

Whilst healthcare outcomes in the UK arguably remain among the best in the world according to recent findings by The …

News
Ebola image

Takeda: we’re working on Ebola too

November 24, 2014
Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya

The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …

News
Antibiotics image

Antibiotics: will the industry saviour please stand up

November 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, EAA, MRC, WHO, resistance, susie lunt

The spectre of a new ‘dark ages’ for humanity where common infections begin to kill again is increasingly making itself …

Feature
Fleming image

Antibiotic resistance ranking high among public concerns

November 18, 2014
Research and Development, Sales and Marketing Antibiotics, Cameron, WHO, longitude, rees, terrorism

People in the UK believe antibiotic resistance is second only to terrorism among threats to the public, according to a …

News
Ebola image

EU and drug industry set aside €280m for Ebola

November 7, 2014
Research and Development, Sales and Marketing Africa, Ebola, WHO, chan, vaccines, virus, west

The EU’s Innovative Medicines Initiative (IMI) has unveiled a new programme to find vaccines, drugs and diagnostics for Ebola, funded …

News
Colorised transmission electron micrograph of Ebola virus virion

Chinese military-linked firm says it has Ebola cure

October 14, 2014
Medical Communications, Sales and Marketing Ebola, WHO, amms, brincidofovir, sihuan pharmaceutical holdings, tekmira, zmapp

A Chinese drugmaker that has close military ties is seeking fast-track approval for its JK-05 drug that it says can …

News

NICE releases ‘person-centred’ medicines optimisation guidelines

October 14, 2014
Research and Development, Sales and Marketing ABPI, NHS, NICE, UK, WHO, Whitehead

NICE has recently released the draft of its first guidance on medicines optimisation that it hopes will be more person-centered …

News
GSK image

GSK Ebola vaccine fast-tracked into human trials

August 28, 2014
Sales and Marketing Africa, Ebola, GSK, WHO, zmapp

GlaxoSmithKline has announced that its experimental Ebola vaccine is being fast-tracked into human studies to help deal with the worst-ever …

News
Ebola image

Untested Ebola drugs can be used in Africa

August 13, 2014
Research and Development, Sales and Marketing Africa, Biocryst Pharmaceuticals, Ebola, Siga Technologies, Tekmira Pharmaceuticals, WHO, world health organization, zmapp

The World Health Organization will allow untested treatments for Ebola to be used in West Africa as the death toll …

News
GSK image

GSK Ebola vaccine underway

August 11, 2014
Research and Development, Sales and Marketing Africa, Ebola, GSK, Vaccine, WHO, johnson

Clinical trials of an experimental vaccine against the deadly Ebola virus will begin soon according to its developers GlaxoSmithKline. The …

News

US doctor infected with Ebola as disease spreads

July 28, 2014
Medical Communications, Sales and Marketing Ebola, WHO

An American doctor working with Ebola patients in Liberia has been infected with the virus as health officials struggle to …

News

More action needed on antibiotic resistance

July 25, 2014
Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh

Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …

News

GAVI vaccine group call for $7.5 billion funding

May 20, 2014
Medical Communications, Sales and Marketing GAVI Alliance, Vaccine, WHO, rotavirus vaccine

The GAVI Alliance is calling on donors to back ambitious plans to immunise an additional 300 million children against potentially …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024